Ifp Advisors, Inc Invitae Corp Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$1.2 - $2.73 $10,160 - $23,114	-8,467 Reduced 99.72%	24 $0
Q4 2022 Feb 07, 2023	SELL	$1.71 - $3.61 $5,449 - $11,505	-3,187 Reduced 27.29%	8,491 $66,000
Q3 2022 Nov 08, 2022	BUY	$1.9 - $8.63 $5,700 - $25,890	3,000 Added 34.57%	11,678 $104,000
Q2 2022 Sep 06, 2022	BUY	$2.13 - $9.01 $18,484 - $78,188	8,678 New	8,678 $82,000
Q2 2022 Aug 12, 2022	SELL	$2.13 - $9.01 $18,484 - $78,188	-8,678 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$6.28 - $15.59 $53,116 - $131,860	8,458 Added 3844.55%	8,678 $69,000
Q3 2021 Oct 06, 2021	SELL	$24.31 - $33.6 $24,358 - $33,667	-1,002 Reduced 82.0%	220 $9,000
Q2 2021 Jul 13, 2021	SELL	$26.09 - $40.4 $89,932 - $139,258	-3,447 Reduced 73.83%	1,222 $40,000
Q1 2021 Apr 30, 2021	BUY	$33.06 - $56.93 $128,206 - $220,774	3,878 Added 490.27%	4,669 $181,000
Q4 2020 Jan 25, 2021	SELL	$39.09 - $57.4 $77,671 - $114,053	-1,987 Reduced 71.53%	791 $37,000
Q3 2020 Oct 29, 2020	BUY	$28.43 - $44.67 $77,045 - $121,055	2,710 Added 3985.29%	2,778 $126,000
Q2 2020 Aug 05, 2020	SELL	$11.71 - $30.29 $2,716 - $7,027	-232 Reduced 77.33%	68 $2,000
Q1 2020 May 12, 2020	BUY	$7.64 - $27.5 $2,292 - $8,250	300 New	300 $5,000
Q4 2019 Jan 17, 2020	SELL	$15.02 - $20.57 $4,205 - $5,759	-280 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$18.85 - $27.5 $5,278 - $7,700	280 New	280 $5,000
Q1 2019 May 15, 2019	SELL	$10.65 - $25.75 $44,996 - $108,793	-4,225 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$9.26 - $16.38 $9,491 - $16,789	1,025 Added 32.03%	4,225 $46,000
Q3 2018 Oct 25, 2018	BUY	$7.54 - $18.31 $24,128 - $58,591	3,200 New	3,200 $0

Others Institutions Holding NVTA

# of Institutions

Shares Held

2.12M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account